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THE USE OF PULMONARY ARTERY SEQUESTRATION AS AN HEPATIC ARTERIAL CONDUIT 
A CASE OF UNUSUAL HEPATIC ARTERIAL SUPPLY' 
J. P. is a 20·month-old Portuguese male patient who pre-
sented with a diagnosis of biliary atresia. Approximately 10 
months previously the patient had undergone a laparotomy and 
cholecystectomy for unexplained jaundice. At the time of sur-
gery the diagnosis of biliary atresia was established, and the 
patient was later transferred for liver transplantation evalua-
tion. 
The physical examination showed a deeply jaundiced infant 
male patient in no apparent distress. Systolic blood pressure 
was 94, heart rate 102, respiratory rate 28, temperature 35.9·C. 
and the weight was 8.9 kg. The sclera were icteric, neck supple, 
lung fields were clear bilaterally, heart was regular and without 
murmurs. Abdominal girth was 52 em with obvious superficial 
venous collaterals. The liver and spleen were enlarged and 
eASily palpable. 
Laboratory studies included: Hct 32%, WBC 9.0, Pit 249K, 
total bilirubin 16.2, GGTP 194, SGOT 268, SGPT 93, and AP 
856. Blood urea nitrogen, creatinine, amylase, and albumin 
were all within normal limits. 
Ultrasonography revealed a cirrhotic liver with patent he-
patic vessels and no bile-duct dilatation. 
The patient was transplanted on 7/15/87 without complica-
tion.. The arterial anastomosis was performed between the 
donor abdominal aorta and the celiac axis ofthe recipient (after 
ligation of the donor left gastric and splenic arteries). On the 
lit postoperative day the patient had an ultrasound that 
showed no pulsation in the hepatic artery. Arterial thrombosis 
was confllmed by angiography. 
The patient was retransplanted the following day (7/17/87) 
with a liver that was slightly smaller than ideal. During the 
huvesting of the liver, it was noted that the donor (a 12-
month-old child) had significant pericardial and right pleural 
adhesions. During the fmal stages of harvesting the liver, a 
large artery was found entering the right lower lobe ofthe lung 
from the diaphragm, an obvioua pulmonary sequestration. The 
arury was preserved and was later found to be emanating from 
the celiac axis. In addition, the liver had a triple arterial supply: 
I Thil work wu aupported by Reseuch Grants from the Veuranl 
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an hepatic artery from the celiac, a left hepatic branch from 
the left gastric artery, and a right hepatic branch from the 
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FIGURE 1. Donor anatomy (above) with rmal reconatruction (be-
low), RHA: right hepatic artery; LHA: left hepatic artery; and SMA: 
superior mesenuric artery. 
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superior mesenteric artery. A modification of the fold-over 
technique (1) was done, but because of the size of the liver 
there was not adequate length to comfortably anastomose this 
complex to the recipient celiac axis. For this reason, the pul-
monary artery originating from the donor celiac axis was used 
to make the anastomosis (Fig. 1). 
The patient recovered from this 2nd transplantation un· 
eventfully and was discharged from the hospital on 8/23/87 
with nonnalliver function. The patency of his arterial complex 
w .. established • times postoperatively by ultrasound On his 
l .. t out-patient visit, he was doing well with a bilirubin of 0 .• , 
PT 11.7 sec., SGOT 19, SGPT 10, and a GTP 16. 
The celiac axis .. the origin of a pulmonary arterial seques-
tration is present 1 % of the time (2). As symptoms of pulmo-
nary sequestration almost always present early in life with 
complications leading to corrective surgery, this anomaly .. a 
harvesting enigma will probably be found only in children. A.. 
was shown here arterial anomalies do not preclude the use of 
the hepatic graft and can often be used advantageously. 
Donor organs should not be discarded secondary to vascular 
anomalies. A thorough understanding of reconstructing the 
hepatic arterial supply can be both organ- and life-saving. 
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SELECTIVE DEPLETION OF KUPFFER CELLS IN MICE BY INTACT RICIN 
Although the results of clinical liver transplantation have 
improved. rejection episodes occur in 35-75% of recipients (1, 
2). While Kupffer cells. endothelial cells, and bile duct cells 
express the class Il (la) antigens of the major histocompatabil-
ity complex (3, 4). which are important in stimulating the 
immune response (5), hepatocytes do not express these anti-
gena. Recent evidence has implicated.transplanted donor Kupf-
fer cella .. an important mediator of hepatic allograft rejection 
(6). These liver macrophages may therefore act .. the "pasaen-
ger leukocyte" of hepatic transplantation. Selectively depleting 
these cella in donor hepatic tissue may therefore decrease donor 
liver immunogenicity. 
Ribosomal inactivating proteins are toxins that are able to 
kill cella in a 1:1 ratio by enzymatically inhibiting the 60S 
subunit of the ribosome (1,8). We have recently used one such 
toxin, the A-chain of ricin, to selectively deplete Kupffer cella 
in rats and mice (9, 10). The A-chain is a mannosylated 
glycoprotein targeted specifically to Kupffer cells presumably 
by the Kupffer cell (macrophage) mannose receptor. After 20 
mcfkg ricin A-chain w .. given intraportally, Kupffer cella in 
mice were successfully reduced by 33% with no evidence of 
hepatic parenchymal damage. This effect persisted for at least 
3 days with recovery evident at 1 week. Unfortunately, higher 
doses of ricin A-chain were not practical due to the development 
of nonspecifK: uptake and systemic toxicitY. In rata, a similar 
reduction in Kupffer cella was observed after injection of 6 mgJ 
kg ricin A-chain intravenoualy but onJy after simultaneous 
bilateral nephrectomy (10). 
This toxicity prompted us to search for a more direct and 
specific toxin to Kupffer cella. In vitro studies bave shown that 
intact ricin, a 65,OOO-dalton heterodimer made up of an A- and 
B-chain. is several times more toxic to Kupffer cells than to 
hepatocytes (11, 12). In vivo studies have also shown that 
labeled intact ricin injected intravenously into rata is prefer-
entially incorporated by the nonparenchymal cells of the liver. 
Also, rat sinusoidal cells have been shown in vivo to be more 
sensitive to ricin than are the parenchymal cells (13,14). This 
raised the possibility of using low doses of intact ricin as a 
toxin specific to Kupffer cella. 
Ricin was purified from castor beans (Ricinu. communis) by 
a protocol previously described (15). Briefly, a crude extract of 
ricin was bound to a 1.5XM>-cm galactose-sepharoae column in 
10 mM Tris-HCI, pH 7.7. Purified ricin w .. then eluted with a 
linear D-galactose, 800 m1. 0-0.12 M gradient. Purity was 
confmned by the presence of a single 65-kilodalton band OD 
9.0% SDS-polyacrylamide gel electrophoresis, and by toxicity 
to cultured rabbit alveolar macrophages. The LDSO (dole at 
which the mortality rate is 50%) of ricin is 2.7 Ilg/k, (14). 
Doaea of 1-2.51lg/kg were uaed in the present study. 
Female Balb/c mice weighing 20 , (Sasco. Indianapolis, IN) 
were grouped into control and treated groups. Single intraportal 
injections of saline (n-") or ricin at the doses described below 
(n=26) were administered 2" hr prior to usay of Kupffer cell 
numbers. Kupffer cell numbers were subsequentJy detenDined 
by phagocytosis of intravenously injected carbon particlea.ln-
die ink (0.1 ee) (Higgins 10k. Faber-Cutell Corp., Newark. NJ), 
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